Market Size (2016)
2016
$820.00M
Vertical: HealthcareBase Year: 201811 Sections
Market Size (2016)
2016
$820.00M
Projected (2024)
2024
$1.29B
CAGR (2016–2024)
5.9%
5.9%Key Players
104+
A stroke occurs when the blood flow to an area of the brain is cut off. This leads to improper supply of oxygen to the cells, which then begin to die. As per the National Stroke Association survey, 2016, around 800,000 people suffer from recurrent stroke every year. It is the fifth leading cause of death in the US. Growing geriatric population, rise in incidences of stroke, and increasing disease awareness drive the growth of the global stroke post processing software market. However, stringent regulatory policies may hamper the growth of the market.
The global stroke post processing software market is expected to register a CAGR of 6.48% during the forecast period of 2019 to 2024. In 2018, the market was led by Europe with 37.9% share, followed by the Americas and Asia-Pacific with shares of 35.6% and 16.4%, respectively.
The global stroke post processing software market has been segmented based on installation, modality, type, end user, and region.
Based on installation, the desktop segment accounted for the largest market share of 48.5% in 2018, with a market value of USD 436.18 million, which is projected to register a CAGR of 6.72% during the forecast period.
On the basis of modality, the CT scan segment accounted for the largest market share of 63.6% in 2018, with a market value of USD 571.43 million, which is projected to register a CAGR of 6.81% during the forecast period.
Based on type, the ischemic stroke segment accounted for the largest market share of 67.5% in 2018, with a market value of USD 606.73 million, which is projected to register a CAGR of 6.57% during the forecast period.
On the basis of end user, the hospitals & clinics segment accounted for the largest market share of 53.4% in 2018, with a market value of USD 479.89 million, which is projected to register a CAGR of 6.72% during the forecast period.
The Stroke Post Processing Software Market market is projected to grow at a CAGR of 5.9% from 2016 to 2024.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansA stroke can be defined as the lack of blood flow to brain tissues, and this can occur in any vascular structure within the brain. Moreover, increasing awareness regarding the benefit of stroke post processing software in individuals as well as healthcare professionals would create more demand for these products. Hence it helps boost the growth of the global stroke post processing software market.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2018
Historical Period
2016 – 2018
Forecast Period
2018 – 2024
Primary Interviews
150+
Historical data (2016–2018) and forecast period (2018–2024)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansBargaining Power of Suppliers
Bargaining power of suppliers in the global stroke post processing software market is low to medium. The suppliers in the global stroke post processing software market are also the manufacturers of this software. Currently, a low number of suppliers are present in the market as the market is new, and the regulatory scenario is stringent. Switching cost of the suppliers is medium because suppliers tend to enter into long-term associations, partnerships, and deals with companies that buy the stroke post processing software.
Bargaining Power of Buyers
The bargaining power of buyers is medium to high in the global stroke post processing software market due to the presence of multiple buyers of stroke post processing software. The buyers of stroke post processing software primarily include diagnostic centers and hospitals. Since very few suppliers are present in the market, buyers can exert moderate pressure on manufacturers. The market is captured by a limited number of players, which indicates oligopoly in the market, which leads to a few options with regard to products offering. Thus, the bargaining power of buyers tends to be medium to high in this market.
The Threat of New Entrants
The threat of new entrants is medium to high in the global stroke post processing software market. Any company trying to enter the stroke post processing software market is required to accept and maintain regulatory standards, and the product must be approved by regulatory authorities. This market has a lot of opportunities for many major medical device companies to enter the market.
Threat of Substitutes
There is no direct substitute for stroke post processing software in the market. Moreover, there are very few market players in the market. So, even though on the internal level, customers can switch from one company’s product to others, the low to medium degree of switching cost may minimize the threat of substitutes. Hence, the threat of substitutes in the global stroke post processing software market is low.
Intensity of Rivalry
The degree of competition in the global stroke post processing software market is medium. Not many manufacturers are present in the market, and it is shared by a few players. The market share of players is fixed, which indicates moderate rivalry. Players are engaged in developing processes to reduce their manufacturing costs to overcome the existing competition. Moreover, players also develop advanced techniques to differentiate their products from their rivals.
Market estimates by geography (2024)
InsightAmericas leads with $476.89M by 2024, while North America is projected to grow fastest at a 6.9% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2016 | 2018 | 2024 | CAGR | SHARE |
|---|---|---|---|---|---|
| Middle East and Africa | $82.16M | $100.48M | $131.77M | 6.1% | 7% |
| North America | $243.08M | $306.57M | $414.64M | 6.9% | 23% |
| Americas | $288.64M | $358.26M | $476.89M | 6.5% | 27% |
| Asia Pacific | $132.27M | $165.77M | $222.79M | 6.7% | 13% |
| Europe | $316.92M | $370.28M | $462.79M | 4.8% | 26% |
| South America | $45.56M | $51.69M | $62.24M | 4.0% | 4% |
| Total | $1.11B | $1.35B | $1.77B | 5.9% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$1.77B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Ischemic Stroke | $1.19B | 5.9% | 72% |
| Hemorrhagic Stroke | $416.14M | 5.9% | 77% |
| Others | $165.46M | 5.9% | 53% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Stroke Post Processing Software Market covering market dynamics, competitive landscape, and strategic outlook.
The Stroke Post Processing Software Market market is projected to reach $1.29B by 2024, growing at 5.9% CAGR. The Ischemic Stroke segment holds the largest share.
Stroke can be defined as lack of blood flow to brain tissue and this can occur in any vascular structure within the brain. Stoke symptoms vary based on individual and region of the brain that has been deprived of blood flow. As per survey carried out by American Stroke Association in 2016, 1,40,000 death can be seen due to stoke in US every year. Hence there is rising demand for stroke post processing software. Software currently available in the market, designed for perfusion of CT studies, are generally divided into two groups such as convolutional and deconvolutional, depending on the use of varied mathematical algorithms. Therefore, even though parameters are given the same name in various software packages, there may be significant disparities between them if they are calculated using different algorithms. The global stroke post processing software market is expected to grow due to increasing burden of Ischemic strokes and rising demand for health care services.
The stroke post processing software market has significant growth potential. Key players in this segment are focusing on partnerships and collaborations to increase their customer base and to enhance geographical presence across the globe. For instance, in January 2019, iSchemaView and NeuroLogica, a subsidiary of Samsung Electronics Co., Ltd. and leader in medical imaging technology, collaborated to integrate iSchemaView’s RAPID cerebrovascular imaging platform with NeuroLogica’s portable CereTom computed tomography (CT) scanners for use in Mobile Stroke Units (MSUs) and Intensive Care Units (ICUs) across the globe. Moreover, in April 2018, Brainomix received USD 9.8 million funding in collaboration with Boehringer Ingelheim in order to bring its software to the market. These collaborations have given iSchemaView and Brainomix to expand globally. As adoption of stroke post processing software in the healthcare industry is increasing, big market players are focusing on collaborating with small companies to expand in the market and for the development of new products in this field. This focus is anticipated to drive the market growth.
Developing economies pose an opportunity for various markets as they have undeveloped research and development sectors owing to which they are unable to address upcoming health challenges. Despite huge demand, the African region is dependent on imported medicines and other health technologies. Although there is a high requirement for treatment, poor economic conditions lead to the slow growth of the healthcare industry within the African region. As per the statistics of the American Stroke Association Report 2016, around 800,000 people in the United States have a stroke and these patients were treated with Stroke Post Processing Software. This huge population affected with the chronic diseases in developing countries serves as a strong opportunity for key players operating in the stroke post processing software market.
Regulatory compliance is the primary hurdle challenging the stroke post processing software market at every point. The growing prevalence of chronic diseases, as well as increased awareness regarding the benefit of stroke post processing software in individuals as well as healthcare professionals, have contributed to rapid growth in the demand for stroke post processing software for treatment of various disorders. Besides, Indian manufacturers are investing more in stroke post processing software transplant to comply with the US FDA regulations for obtaining contracts from the US-based companies. Although these regulations are serving to improve and maintain the quality of these devices, they are also curbing the growth of the devices manufacturing market especially in developing regions of Asia-Pacific.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 104 companies operating in the Stroke Post Processing Software Market market, including revenue, employee count, and market positioning where available.
Showing 104 of 104 companies
Brainomix
Company Headquarters: Oxford, UK Founded: 2010 Workforce: ~50 Company Working: Brainomix is a start-up by the University of Oxford. It develops medical imaging software that can automatically interpret brain CT scans of patients who have suffered a stroke or are undergoing diagnosis for it. It develops imaging biomarkers for neurological and cerebrovascular disorders. The software supports physicians in identifying the patients that can benefit from life-saving stroke treatment. The company has a team of expert clinicians, stroke neurologists, scientists, business professionals, and engineers who give necessary insights and experience to cater to the demands of its customers. The company offers e-Aspects which is a medical imaging software that automates the Alberta Stroke Program Early CT Score system. This helps create brain images from acute ischemic stroke patients to identify and quantify signs of early stroke damage and assist the physician's decision of how to treat the disease. The company’s software evaluates stroke damage on brain CT scans, addresses the lack of brain CT scan interpretation availability, and guides assessment of eligibility of stroke patients for life-saving treatment.
General Electric Company
Company Headquarter: US Founded: 1892 Workforce: 283,000 Company Working: General Electric Company is a technology and financial services company that develops and manufactures products for the generation, transmission, distribution, control, and utilization of electricity. The company offers aircraft engines, power generation, water processing, security technology, medical imaging, business and consumer financing, media content, and industrial products. GE operates through two major segments—industrial and capital. The industrial segment consists of 8 different sub-segments, namely, power, oil & gas, energy, aviation, healthcare, transportation, appliances and lighting, and GE capital. The Power segment offers power generation and energy production. The Oil & Gas segment provides mission-critical equipment for Oil & Gas companies. The Energy segment provides wind turbine platforms, hydropower products and services, and blades for wind turbines. The Aviation segment manufactures jet engines, turboprops, maintenance, engineering, and overhaul services. The Healthcare segment provides diagnostic imaging and clinical systems, drug discovery solutions, gene therapy technologies, and medical technologies. The Transportation segment offers freight and passenger locomotives, rail parts, data analytics, and rail integrated software solutions. The Appliances & Lighting segment manufactures LED products, refrigerators, cooktops, microwave ovens, hybrid water heaters, energy efficiency, and productivity solutions. The GE Capital segment offers financial services such as commercial loans and leases, consulting services, and fleet management. GE Power’s Grid Solutions is one of the subsidiaries which provide the energy leader that provides technology, solutions, and services across the entire energy value chain. The company operates across the world in the Americas, EMEA (Europe, Middle East, and Africa), and Asia-Pacific and has several subsidiaries including GE Capital, GE Digital, GE Energy Connections, and GE Global Research.
Koninklijke Philips NV
Company Headquarters: Amsterdam, Netherlands Founded: 1891 Workforce: 77,000 (2018) Company Working: Koninklijke Philips NV (Philips) is a market leader in healthcare technology. The company has a strong sales and distribution network worldwide and operates in more than 100 countries. Philips offers products through segments, including medical devices, health systems, cardiology, health tech, oncology, respiratory, fertility, and pregnancy. The company deals in maternity care, child care, and oral healthcare products; male grooming and beauty products; food preparation and home care products; and sleep and respiratory care products. It delivers diagnostic X-ray, integrated clinical, magnetic resonance imaging, computed tomography, and molecular imaging solutions. Moreover, the company also offers healthcare information technology, clinical, and visualization and quantification informatics solutions for radiology, cardiology, and oncology; universal data management solutions, picture archiving and communication systems, and integrated electronic medical record systems; clinical and hospital IT platforms; technology-enabled monitoring and intervention, actionable program, cloud-based, and population health management software solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013.
Siemens AG
Company Headquarters: Munich, Germany Founded: 1847 Workforce: ~372,000 Company Working: Siemens is an industrial conglomerate that operates in automation, electrification, and digitalization fields, globally. It offers power generation products for utilities, independent power producers, industrial customers, and engineering, procurement, and construction (EPC) customers. The company has nine business divisions, which are power & gas, energy management, building technologies, mobility, digital factory, process industries & drives, Healthineers, Siemens Gamesa Renewable Energy, and financial services. It offers industrial gearbox through its subsidiary Flender GmbH, which based in Germany. Siemens also offers products such as parts manufacturing shop, gear cutting shop, housing machining shop, and hardening shop, which are used in industrial operations along with industrial gearbox. It offers industrial gearboxes to a wide range of end-use industries such as cement and mining, cranes, marine & shipbuilding, oil & gas, power generation, chemicals & pharmaceuticals, rubber & plastic, pulp & paper, and water & wastewater. Currently, the company has a presence in around 200 countries, globally. Siemens offers products for applications in the automotive, marine, wind power, transmission & distribution, and nuclear industries. Its major subsidiaries are Gamesa Energie Deutschland GmbH (Germany), Siemens Power Control GmbH (Germany), Siemens Compressor Systems GmbH (Germany), ESTEL Rail Automation SPA (Algeria), and Siemens Electric Machines s.r.o. (Czech Republic). Emerson Electric Co., Sumitomo Heavy Industries Ltd, Watt Drive Weg Group, Bonfiglioli, Schneider Electric, and Johnson Electric Holdings Limited are some of its major competitors.
Novavax, Inc.
Company Headquarters: Maryland, US Founded: 1987 Workforce: ~2,500 Company Working: Novavax, Inc. is a biotechnology company that commercializes and develops vaccines to prevent a wide range of infectious diseases. It designs recombinant nanoparticle vaccine technology that produces a strong immune response against a variety of pathogens. It is partnered with leading biopharma organizations, government agencies, research institutions, and foundations, namely the Coalition for Epidemic Preparedness Innovations (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), the Serum Institute of India Pvt. Ltd. (India), SK Bioscience (South Korea), CPL Biological (India), and Takeda Pharmaceuticals (US). It has seven research and manufacturing facilities. It has presence in regions namely North America, Europe, and the Middle East and Africa
Ology Bioservices, Inc
Company Headquarters: Florida, US Founded: 1999 Workforce: ~800 Company Working: Ology Bioservices, Inc. is an integrated biopharmaceutical company that develops and manufactures biopharmaceuticals and medical devices. It specializes in cell therapy, gene therapy, viral vectors, antibodies, oncolytic viruses, biopharmaceutical manufacturing, and vaccines. It has collaboration and partnerships with recognized government agencies, namely the Department of Defense and Medical Countermeasures Advanced Development and Manufacturing, which support it in developing biodefense products. Moreover, it has decades of experience in developing, licensing, and manufacturing proteins, therapeutics, and vaccines. It develops products to offer both commercial customers and US governments. Furthermore, it is a wholly owned company of National Resilience, Inc. (US), and assisting Resilience through its services includes regulatory support from preclinical through licensure and cGMP manufacturing up to biosafety level 3 (BSL3).
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Stroke Post Processing Software Market